Bruna Lima Chechin Catussi

Bruna Lima Chechin Catussi


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2024 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
BCBruna Lima Chechin Catussi
Bruna Lima Chechin Catussi
ETEdson Guimarães Lo Turco
Edson Guimarães Lo Turco
DPDirceu Mendes Pereira
Dirceu Mendes Pereira
RTRafael Matheus Nunes Teixeira
Rafael Matheus Nunes Teixeira
BCBárbara Prestes Castro
Bárbara Prestes Castro
IMIrineu Francisco Delfino Massaia
Irineu Francisco Delfino Massaia

1 January 2023 in Animal Reproduction
Verified
Journal Article
Open access
PDF file
PBPietro Baruselli
Pietro Baruselli
LALaís Ângelo de Abreu
Laís Ângelo de Abreu
BCBruna Lima Chechin Catussi
Bruna Lima Chechin Catussi
AOAna Carolina dos Santos Oliveira
Ana Carolina dos Santos Oliveira
LRLígia Mattos Rebeis
Lígia Mattos Rebeis
CRCarlos Alberto Rodrigues
Carlos Alberto Rodrigues
Currently, gonadotropin products (follicle stimulating hormone, FSH, and luteinizing hormone, LH) used in animal reproduction are produced by extraction and purification from abattoir-derived pituitary glands. This method, relying on animal-derived materials, carries the potential risk of hormone contamination and pathogen transmission. Additionally, chorionic gonadotropins are extracted from the blood of pregnant mares (equine chorionic gonadotropin; eCG) or the urine of pregnant women (human chorionic gonadotropin; hCG). However, recent advancements have introduced recombinant gonadotropins for assisted animal reproduction therapies. The traditional use of FSH for superovulation has limitations, including labor requirements and variability in superovulation response, affecting the success of in vivo (SOV) and in vitro (OPU/IVEP) embryo production. FSH treatment for superstimulation before OPU can promote the growth of a homogenous follicular population and the recovery of competent oocytes suitable for IVEP procedures. At present, a single injection of a preparation of long-acting bovine recombinant FSH (rFSH) produced similar superovulation responses resulting in the production of good-quality in vivo and in vitro embryos. Furthermore, the treatment with eCG at FTAI protocol has demonstrated its efficacy in promoting follicular growth, ovulation, and P/AI, mainly in heifers and anestrous cows. Currently, treatment with recombinant glycoproteins with eCG-like activity (r-eCG) have shown promising results in increasing follicular growth, ovulation, and P/AI in cows submitted to P4/E2 -based protocols. Bovine somatotropin (bST) is a naturally occurring hormone found in cows. Recombinant bovine somatotropin (rbST), produced through genetic engineering techniques, has shown potential in enhancing reproductive outcomes in ruminants. Treatment with rbST has been found to improve P/IA, increase donor embryo production, and enhance P/ET in recipients. The use of recombinant hormones allows to produce non-animal-derived products, offering several advantages in assisted reproductive technologies for ruminants. This advancement opens up new possibilities for improving reproductive efficiency and success rates in the field of animal reproduction.

27 April 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BCBruna Lima Chechin Catussi
Bruna Lima Chechin Catussi
JFJaqueline Rodrigues Ferreira
Jaqueline Rodrigues Ferreira
ETEdson Guimarães Lo Turco
Edson Guimarães Lo Turco
SMSérgio Carlos Franco Morgulis
Sérgio Carlos Franco Morgulis
PBPietro Sampaio Baruselli
Pietro Sampaio Baruselli
This experiment evaluated the influence of creep feeding supplementation on productive and reproductive performance and on serum metabolome profile in Nelore (Bos indicus) heifers. Female calves were assigned to treatments: Creep (n = 190), with ad libitum access to a nutritional supplement from 70 to 220 days after birth, or Control (n = 140), without supplementation. After weaning (Day 220), both groups followed the same pasture and nutritional management. Body weight (BW) and backfat thickness (BFAT) were measured over time. Blood samples were collected at 220 and 360 days for LC–MS/MS targeted metabolomics. On day 408, during the synchronization timed artificial insemination (TAI) protocol, reproductive status (RS: diameter of uterine horn and largest follicle, and presence of CL) was assessed. Creep feeding increased BW and BFAT at weaning, but no differences in BW, BFAT, or RS after weaning were observed. Nonetheless, the pregnancy per AI (P/AI) for 1st service was 28.9% higher in the Creep group. On day 220, 11 significant metabolites influenced five metabolic pathways: Glucose-alanine cycle, alanine, glutathione, phenylalanine and tyrosine metabolism, and urea cycle. On day 360, 14 significant metabolites influenced eight metabolic pathways: Malate-aspartate shuttle, arginine and proline metabolism, urea cycle, aspartate, beta-alanine, glutamate metabolism, ammonia recycling and citric acid cycle. In conclusion, creep feeding supplementation improved calf performance and induced metabolic changes at weaning and 360 days of age. Although heifers had similar productive performance and reproductive status, when submitted to TAI, those supplemented with creep feeding had greater P/AI.

2 May 2022 in Animal Bioscience
Verified
Journal Article
Open access
PDF file
BCBruna Lima Chechin Catussi
Bruna Lima Chechin Catussi
LSLaísa Garcia da Silva
Laísa Garcia da Silva
FJFernando José Schalch Júnior
Fernando José Schalch Júnior
RARafaela Maria Sutiro Angelieri Auder
Rafaela Maria Sutiro Angelieri Auder
JGJuan Morales Gómez
Juan Morales Gómez
PBPietro Baruselli
Pietro Baruselli
Objective: Pregnant Nelore heifers (n = 417) were used to evaluate the effects of supplementation with monensin-molasses multinutrient block (B) during pre and/or postpartum on reproductive and progeny performance.Methods: Heifers were allocated in four treatments: i) CC: heifers received control supplement (C) in loose meal form (0.06% of body weight [BW] offered daily before and after parturition; n = 108); ii) CB: received C before parturition and B (0.07% of BW offered weekly after parturition; n = 117); iii) BC: received B before and C after parturition (n = 103) and iv) BB: received B before and after parturition (n = 89). During pre and postpartum periods, concentration of metabolites/hormones and cow/calf performance was evaluated over time. Cows were synchronized twice for fixed timed artificial insemination (FTAI) using an estradiol/progesterone-based protocol. Data was analyzed by orthogonal contrasts (C).Results: B increased pregnancy at first FTAI (p = 0.04) and overall pregnancy rate (C1: CC vs BB+BC+CB; p = 0.05). Supplemented cows had greater body condition score (BCS) only at parturition (D0; p = 0.04) and at D40 (p = 0.02). B increased BW (p = 0.03), glucose concentrations (p = 0.01) and subcutaneous fat thickness (p = 0.03) only at D40. Concentrations of insulin were higher in supplemented cows (p = 0.008). Calves born by cows supplemented before and after parturition (C2: BB vs BC+CB) were heavier at 80 (p<0.001), 120 (p<0.001), 170 (p = 0.002) and 210 (p = 0.02) days old.Conclusion: Regardless of period of treatment, block supplementation increased pregnancy at first FTAI and overall pregnancy rate. Additionality, block supplementation during both pre and postpartum periods improved progeny weight until weaning. Block supplementation can be a tool to optimize fertility and calf performance in Nelore primiparous cows.

26 May 2025 in Theriogenology
Verified
Journal Article
Closed access
BCBruna Lima Chechin Catussi
Bruna Lima Chechin Catussi
RRRomulo Germano de Rezende
Romulo Germano de Rezende
Pedro Nacib Jorge-NetoPedro Nacib Jorge-Neto
Pedro Nacib Jorge-Neto
LGLaura Nataly Garcia-Oliveros
Laura Nataly Garcia-Oliveros
EGEmanuele Almeida Gricio
Emanuele Almeida Gricio
PBPietro Sampaio Baruselli
Pietro Sampaio Baruselli

26 March 2022 in Revista Principia
Verified
Journal Article
Open access
BCBruna Lima Chechin Catussi
Bruna Lima Chechin Catussi
RMRodrigo Garcia Motta
Rodrigo Garcia Motta
LSLuan Sitó da Silva
Luan Sitó da Silva
Flavio Augusto Vicente SeixasFlavio Augusto Vicente Seixas
Flavio Augusto Vicente Seixas
ANAdalgiza Pinto Neto
Adalgiza Pinto Neto
AMAntonio Campanha Martinez
Antonio Campanha Martinez
O objetivo deste estudo foi caracterizar a transferência da imunidade passiva, por meio da concentração de proteína plasmática total (PT), em cordeiros alimentados com colostros bovino ou ovino. Foram utilizados 36 animais, divididos em dois grupos. Os cordeiros do tratamento 1 (T1) receberam colostro de vaca, enquanto, os do tratamento 2 (T2) receberam colostro de ovelha. As amostras de sangue foram coletadas em 5 momentos: H0 (ao nascer), H2 (duas após parto), H6 (seis horas após parto), H12 (doze horas após parto) e H24 (24 horas após parto). A dosagem da proteína plasmática foi realizada por espectrofotometria e os dados foram analisados pelo software Origin 6.0. O valor médio da proteína total plasmática dos cordeiros na primeira coleta de sangue (H0) foi de 1,73±1,31 g/dL (T1) e 1,95±1,05 g/dL (T2). No H2 encontrou-se 2,13±1,11 (T1) e 2,24±0,97 (T2). Já no momento (H6) foi de 3,06±1,40 (T1) e 3,74±3,25 (T2). No momento (H12) foi de 3,92±1,81 (T1) e 5,50±3,74 (T2), e nas vinte e quatro horas após a coleta (H24), foi de 3,97±1,70 (T1) e 4,04±2,26 (T2). Não houve diferença significativa entre os grupos. Conclui-se, portanto, que há transferência de imunidade passiva para cordeiros neonatos que receberam colostro de diferentes origens e que a mensuração da proteína plasmática é um importante biomarcador da eficácia da colostragem em cordeiros.